Outside the US it is supplied as a research-grade peptide and is not approved for human use by any major regulator
It also has been linked to influencing other growth pathways, like increasing gene expression for repair and even modulating neurotransmitter systems (dopamine, serotonin, etc., in brain injury models)
The precursor to TMAO, trimethylamine, on the other hand impairs BBB function, emphasizing the need to better understand the relationships between microbial-derived metabolites, host processing of these metabolites and BBB physiology [155]
Safety discussions depend heavily on regulatory approval status and medical supervision
We administer BPC-157 injections with precision, ensuring targeted delivery for optimal results